Skip to content

Factors Associated With Clinical Pregnancy Outcomes in Intrauterine Insemination (IUI) Cycles

Factors Associated With Clinical Pregnancy Outcomes in Intrauterine Insemination (IUI) Cycles

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07344623
Enrollment
3000
Registered
2026-01-15
Start date
2026-01-13
Completion date
2028-01-01
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive Issues

Brief summary

Hypotheses: We hypothesize that variations in hormonal profiles (LH, estradiol, progesterone) during ovarian stimulation, follicular response, endometrial characteristics, and sperm quality parameters are significantly associated with clinical pregnancy outcomes in intrauterine insemination (IUI) cycles. Aims * To investigate the association between hormonal profiles on the trigger day (LH, estradiol, progesterone), follicular response, endometrial thickness, and sperm parameters with clinical pregnancy outcomes in IUI cycles. * To develop and validate a predictive model for clinical pregnancy incorporating key determinants such as female age, hormonal response, endometrial characteristics, and sperm quality. * To compare natural and gonadotropin-stimulated IUI cycles in terms of hormonal profiles, pregnancy outcomes, and cost-effectiveness. Primary Outcome Clinical pregnancy rate (CPR), defined as the presence of a gestational sac with a fetal heartbeat on ultrasound at approximately 6 weeks of gestation following intrauterine insemination. Secondary Outcomes * Biochemical pregnancy rate. * Ongoing pregnancy rate * Live birth rate

Detailed description

Statistical Analysis Each sub-study will employ specific analytical approaches: * Univariate and multivariate logistic regression for associations * Mediation and interaction analysis * ROC and AUC analysis for predictive modeling * Machine learning for model development * Cost-effectiveness evaluated via incremental cost per clinical pregnancy Consent This is a retrospective study, and thus, there is no need for a written informed consent. Sample Size All eligible IUI cycles, estimated to be approximately 3000 cycles, will be included

Interventions

None listed

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* Couples who underwent at least one IUI-intrauterine insemination cycle.

Exclusion criteria

* Couples who used donor sperm. * Cases with missing core outcome data

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy rate (CPR)6 weeks gestation and ultrasound scanning will be performed to confirm at least one gestational sac around 2 to 3 months after IUI.Rate of clinical pregnancy outcome in subjects undergoing IUI

Secondary

MeasureTime frameDescription
Biochemical pregnancy rateUp to 12 weeksRate of biochemical pregnancy outcome in subjects undergoing IUI
Ongoing pregnancy rateUp to 12 weeksRate of Ongoing pregnancy outcome in subjects undergoing IUI
live birth rateUp to 40 weeksRate of live birth rate outcome in subjects undergoing IUI

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026